About ARCTOS medical
ARCTOS medical is a company based in Bern (Switzerland) founded in 2018 was acquired by Novartis in September 2021. ARCTOS medical operates in a competitive market with competitors including EyePoint Pharmaceuticals, Rezolute, Molecular Partners, Aviceda Therapeutics and IVERIC bio, among others.
- Headquarter Bern, Switzerland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ARCTOS medical
Detailed funding history for ARCTOS medical
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in ARCTOS medical
ARCTOS medical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Novartis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
Locked | Locked | Locked |
Investor details for ARCTOS medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ARCTOS medical
Investment portfolio details for ARCTOS medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ARCTOS medical
Detailed financials for ARCTOS medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Arctos Medical Comparisons
Peer comparison for ARCTOS medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ARCTOS medical
ARCTOS medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EyePoint Pharmaceuticals, Rezolute, Molecular Partners, Aviceda Therapeutics and IVERIC bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Small molecule therapeutics for ophthalmic disorders are developed.
|
|
| Locked | Locked | Locked |
Therapies for metabolic and orphan diseases are developed by Rezolute.
|
|
| Locked | Locked | Locked |
Therapeutic solutions for diseases are developed using DARPin technology.
|
|
| Locked | Locked | Locked |
Biotherapeutics for glycol-immune diseases are developed across multiple therapeutic areas.
|
|
| Locked | Locked | Locked |
Gene therapy solutions for retinal diseases are developed.
|
|
| Locked | Locked | Locked |
Therapies for ophthalmological diseases are developed to restore vision.
|
Detailed competitors of ARCTOS medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Arctos Medical
Complete news archive for ARCTOS medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ARCTOS medical
ARCTOS medical was founded in 2018.
ARCTOS medical is headquartered in Bern, Switzerland. It is registered at Bern, Bern, Switzerland.
ARCTOS medical was founded in 2018 in Bern, Switzerland, within the biotechnology sector. Optogenetic therapies targeting retinal degenerative diseases are developed using adeno-associated virus gene therapy. Replacement photoreceptors incorporating optogenes are designed to activate specific cells in the retina. Applications focus on addressing blindness linked to conditions such as retinitis pigmentosa and age-related macular degeneration. Operations center on preclinical and clinical advancements in gene-based vision restoration.
ARCTOS medical's top competitors include EyePoint Pharmaceuticals, Rezolute and Molecular Partners.
ARCTOS medical has 1 investor. Key investors include Novartis.